Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Preferred Shares (2016 - 2017)

Apyx Medical's Preferred Shares history spans 5 years, with the latest figure at $1000.0 for Q2 2017.

  • For Q2 2017, Preferred Shares fell 50.0% year-over-year to $1000.0; the TTM value through Jun 2017 reached $1000.0, down 50.0%, while the annual FY2016 figure was $1000.0, 50.0% down from the prior year.
  • Preferred Shares reached $1000.0 in Q2 2017 per APYX's latest filing, roughly flat from $1000.0 in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $3.2 million in Q4 2014 to a low of $1000.0 in Q4 2016.
  • Average Preferred Shares over 5 years is $645769.2, with a median of $2000.0 recorded in 2015.
  • Peak YoY movement for Preferred Shares: surged 41.21% in 2014, then crashed 99.94% in 2015.
  • A 5-year view of Preferred Shares shows it stood at $2.3 million in 2013, then skyrocketed by 41.21% to $3.2 million in 2014, then plummeted by 99.94% to $2000.0 in 2015, then crashed by 50.0% to $1000.0 in 2016, then changed by 0.0% to $1000.0 in 2017.
  • Per Business Quant, the three most recent readings for APYX's Preferred Shares are $1000.0 (Q2 2017), $1000.0 (Q1 2017), and $1000.0 (Q4 2016).